Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CAR-T
Biotech
Caribou cuts 32% of staff, further purges cell therapy pipeline
The cuts are Caribou's second in less than a year, following another layoff round and the shuttering of an NK cell therapy program in July 2024.
Darren Incorvaia
Apr 24, 2025 9:55pm
Patient suffers side effect in Cabaletta CAR-T trial
Apr 2, 2025 6:55am
BioNTech passes on Autolus' CAR-T amid pipeline prioritization
Mar 20, 2025 9:11am
AstraZeneca goes in vivo, pens $1B deal for lentiviral biotech
Mar 17, 2025 7:40am
Cabaletta's CAR-T shows 'robust benefit' in autoimmune patients
Feb 19, 2025 11:10am
Allogene’s lymphoma data show CAR-T could ‘leapfrog’ competition
Feb 14, 2025 10:35am
